history
Search in
1 service found
Sort by:
Relevance

Testing

Fluofarma

Service Description

CLIENTS NEED OPERATIONAL DELIVERABLES Progress and final reports, which include raw data, key parameter statistics and interpreted results, are systematically discussed with clients to support their decision making. A 360-DEGREE SCIENTIFIC EVALUATION Assay development projects are elaborated by dedicated study designers - PhD staff with extensive lab experience. Study designers are in charge of exploring the research field linked to the client’s request through an in-depth literature review. Within 1 to 2 weeks, in accordance with the lab director, several options for assay design are submitted to the client for discussion. A TRANSPARENT COLLABORATIVE PROCESS A joint steering committee (JSC) is formed at the start of the project. On our side, the JSC typically includes the study director in charge of the project, the research engineer and the study designer. JSC meetings ensure smooth and transparent project progress. They also give us the opportunity to present and discuss results in detail with clients. IN-HOUSE PERFORMANCE OR ASSAY TRANSFER To ensure safe & fast screening campaign implementation, newly-developed assays are generally performed at Fluofarma. However, we also offer to support assay transfer to your facilities, through the delivery of standard operating procedures (SOP) and staff training.

Details

  • SegmentPersonal care
  • Regions activeEMEA

Specialized in

Sample work

CompanyLogo

  • Company nameFluofarma
  • Legal nameFLUOFARMA SA
  • HeadquartersPessac, France
  • Number of employees1-100
  • DescriptionAs a preclinical contract research organization (CRO), we now have 10 years of experience in assay development. We know that the two critical success factors in R&D outsourcing are the initial project evaluation and the establishment of a trustful client/provider relationship based on dynamic scientific interactions. We therefore operate a specific workflow pattern to support assay development in the context of drug discovery studies and clinical trials.